Neothetics’ Belly-Busting Shot Lipo-202 Enters Phase 3 Trials
The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.
The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.
Sofwave Medical Ltd reported a 56% revenue increase and $1 million in net income for the third quarter of 2025.